Rising Focus on ‚Inceptor‘ as a Type 2 Diabetes Therapeutic Target
Research targeting the insulin-inhibitory receptor, called inceptor, unveils promising avenues for beta cell protection, offering hope for causal diabetes therapy. A novel study in mice with diet-i…
